Yang et al. published findings on self-assembling nanoparticles that target cluster of differentiation 44 (CD44) to deliver MDR1 siRNA specifically to cancer cells in a mouse PDX model of ovarian cancer. This evidence concerns the gene ABCB1 and ovarian cancer.